Walleye Capital LLC
- SEC CIK
- 0001758720
- Latest filing
- Aug 3, 2026
MYGN holding history
Myriad Genetics Inc in every 13F filed by Walleye Capital LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MYGN overviewAll 13F holders of MYGNFull Q2 2026 holdings
- Shares (Q2 2026)
- 464,647
- Value
- $2.65M
- % of portfolio
- <0.1%
- Quarters held
- 12
- Since Q3 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 464,647 | $2.65M | <0.1% | +464,647 | New | Holders |
| Q1 2026 | 0 | $0 | 0.0% | −677,176−100.0% | Sold out | Holders |
| Q4 2025 | 677,176 | $4.16M | <0.1% | +277,319+69.4% | Added | Holders |
| Q3 2025 | 399,857 | $2.89M | <0.1% | +354,385+779.3% | Added | Holders |
| Q2 2025 | 45,472 | $241.5K | <0.1% | −141,130−75.6% | Reduced | Holders |
| Q1 2025 | 186,602 | $1.66M | <0.1% | +186,602 | New | Holders |
| Q1 2024 | 0 | $0 | 0.0% | −17,228−100.0% | Sold out | Holders |
| Q4 2023 | 17,228 | $329.7K | <0.1% | +16,907+5,267.0% | Added | Holders |
| Q3 2023 | 321 | $5.15K | <0.1% | +321 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −26,149−100.0% | Sold out | Holders |
| Q1 2023 | 26,149 | $607.4K | <0.1% | −12,977−33.2% | Reduced | Holders |
| Q4 2022 | 39,126 | $567.7K | <0.1% | +17,880+84.2% | Added | Holders |
| Q3 2022 | 21,246 | $405.0K | <0.1% | +21,246 | New | Holders |
| Q2 2022 | 0 | $0 | 0.0% | −15,852−100.0% | Sold out | Holders |
| Q1 2022 | 15,852 | $399.0K | <0.1% | +15,852 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −7,381−100.0% | Sold out | Holders |
| Q3 2021 | 7,381 | $238.0K | <0.1% | +7,381 | New | Holders |